Exactech Unveils Latest Innovations in AI and Polyethylene Technology at ORS 2025 Conference
In a significant presentation at the 2025 Orthopaedic Research Society (ORS) Annual Meeting held in Phoenix, Arizona, Exactech, a worldwide leader in medical technology, introduced 15 cutting-edge studies focusing on advancements in total joint arthroplasty and trauma solutions. The research highlighted the company’s forward-looking use of artificial intelligence (AI) and machine learning (ML), particularly in areas like image segmentation and predictive modeling.
The studies unveiled at the conference also included detailed CT image-based radiomic analysis, insights from computer-assisted surgical navigation, and findings from clinical outcomes research. Furthermore, innovations in implant materials were showcased, demonstrating Exactech's commitment to enhancing surgical practices and patient recovery rates.
A notable ML-focused study examined pre-operative CT scans of the deltoid muscle, assessing how various image acquisition and processing parameters impact the extraction of vital radiomic measurements. The research successfully identified stable radiomic features across different scanning protocols. The study concluded that shape-based features tended to remain the most stable, while second-order texture features were more susceptible to changes in image processing parameters. Another study made connections between these stable radiomic features and the range of shoulder motion patients had prior to shoulder arthroplasty. Findings suggested that specific deltoid radiomic features could predict both pre-operative and post-operative motion, a breakthrough for surgeons as it introduces a method previously absent from shoulder evaluations.
Chris Roche, Senior Vice President of Extremities at Exactech, emphasized the importance of these findings, stating, "These radiomic studies provide new insights that can be incorporated into pre-operative planning software with applications for improved clinical decision support tools. Shoulder surgeons do not currently assess the deltoid using any quantitative method when considering their patients for shoulder arthroplasty. Our new research not only provides a repeatable method to quantitatively assess the deltoid, but we also identified the specific radiomic features that are clinically meaningful and predictive of shoulder arthroplasty outcomes."
Beyond imaging and analysis, Exactech reaffirmed its dedication to superior materials with its Activit-E® polyethylene, exhibiting remarkable oxidation resistance and mechanical resilience in joint arthroplasty applications. The material was shown to outperform traditional ultra-high-molecular-weight polyethylene (UHMWPE) in rigorous knee wear tests and simulated aging conditions. The peroxide crosslinked and vitamin E-stabilized makeup of Activit-E is designed to promote greater implant longevity and improve patient outcomes.
Luis Alvarez, Director of Engineering and Development at Exactech, noted, "These findings reinforce Exactech's commitment to developing the most advanced implant materials that offer greater durability and performance. With our new Activit-E polyethylene, we are advancing material technology to improve long-term success in total joint replacements."
Additional research presented at the meeting illustrated the development of a novel 3D classification approach for total knee arthroplasty (TKA) patients using unsupervised machine learning clustering models, which aligns with the company's Newton® Knee balancing technology.
In summary, Exactech's presence at ORS 2025 not only highlights the role of AI and advanced materials in orthopedic surgery but also sets a precedent for future innovations that could significantly enhance clinical procedures and patient care outcomes. To stay updated with Exactech's advancements in orthopedic technology, visit their official website at www.exac.com.
The studies unveiled at the conference also included detailed CT image-based radiomic analysis, insights from computer-assisted surgical navigation, and findings from clinical outcomes research. Furthermore, innovations in implant materials were showcased, demonstrating Exactech's commitment to enhancing surgical practices and patient recovery rates.
A notable ML-focused study examined pre-operative CT scans of the deltoid muscle, assessing how various image acquisition and processing parameters impact the extraction of vital radiomic measurements. The research successfully identified stable radiomic features across different scanning protocols. The study concluded that shape-based features tended to remain the most stable, while second-order texture features were more susceptible to changes in image processing parameters. Another study made connections between these stable radiomic features and the range of shoulder motion patients had prior to shoulder arthroplasty. Findings suggested that specific deltoid radiomic features could predict both pre-operative and post-operative motion, a breakthrough for surgeons as it introduces a method previously absent from shoulder evaluations.
Chris Roche, Senior Vice President of Extremities at Exactech, emphasized the importance of these findings, stating, "These radiomic studies provide new insights that can be incorporated into pre-operative planning software with applications for improved clinical decision support tools. Shoulder surgeons do not currently assess the deltoid using any quantitative method when considering their patients for shoulder arthroplasty. Our new research not only provides a repeatable method to quantitatively assess the deltoid, but we also identified the specific radiomic features that are clinically meaningful and predictive of shoulder arthroplasty outcomes."
Beyond imaging and analysis, Exactech reaffirmed its dedication to superior materials with its Activit-E® polyethylene, exhibiting remarkable oxidation resistance and mechanical resilience in joint arthroplasty applications. The material was shown to outperform traditional ultra-high-molecular-weight polyethylene (UHMWPE) in rigorous knee wear tests and simulated aging conditions. The peroxide crosslinked and vitamin E-stabilized makeup of Activit-E is designed to promote greater implant longevity and improve patient outcomes.
Luis Alvarez, Director of Engineering and Development at Exactech, noted, "These findings reinforce Exactech's commitment to developing the most advanced implant materials that offer greater durability and performance. With our new Activit-E polyethylene, we are advancing material technology to improve long-term success in total joint replacements."
Additional research presented at the meeting illustrated the development of a novel 3D classification approach for total knee arthroplasty (TKA) patients using unsupervised machine learning clustering models, which aligns with the company's Newton® Knee balancing technology.
In summary, Exactech's presence at ORS 2025 not only highlights the role of AI and advanced materials in orthopedic surgery but also sets a precedent for future innovations that could significantly enhance clinical procedures and patient care outcomes. To stay updated with Exactech's advancements in orthopedic technology, visit their official website at www.exac.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.